CHNA
Loncar China BioPharma ETF
CHNA
CHNA
Delisted
CHNA was delisted on the 20th of October, 2023.
4 hedge funds and large institutions have $403K invested in Loncar China BioPharma ETF in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
4
Holders Change
+2
Holders Change %
+100%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$347K |
| 2 |
AG
Advisor Group
Phoenix,
Arizona
|
+$11K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1K |
Top Sellers
| 1 |
Jane Street
New York
|
-$270K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $347K | +$347K | +16,162 | New |
|
2
Morgan Stanley
New York
| $44K | – | – | – |
|
|
AG
3
Advisor Group
Phoenix,
Arizona
| $11K | +$11K | +500 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $1K | +$1K | +44 | New |
|
|
5
Jane Street
New York
| – | -$270K | -12,166 | Closed |
|